Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Kempton

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Journal of Medical Virology|April 1, 2020
Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysisMatthew J Kempton
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 9, 2021
Linking Brain Age to Psychopathology in AdolescenceMatthew J Kempton
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 6, 2014
How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?Matthew J Kempton, Philip McGuire
Biological Psychiatry|March 31, 2019
Reply to: Odds and Risk Ratios: When They Are Similar and When They Are NotAlexis E Cullen, Matthew J Kempton
JAMA Psychiatry|November 15, 2023
Concerns Regarding Strength of Conclusions in Systematic Review and Meta-Analysis of Neuroradiological Abnormalities in First-Episode Psychosis-ReplyGraham Blackman, Matthew J Kempton, Philip McGuire
Schizophrenia Research|March 19, 2025
A systematic review and meta-analysis of employer discrimination towards people living with psychosisNinon Crestois, Matthew J Kempton, Ricardo Twumasi
The Lancet. Psychiatry|August 30, 2016
Using machine learning to predict outcomes in psychosisJonathan Young, Matthew J Kempton, Philip McGuire
Neuroscience and Biobehavioral Reviews|April 3, 2014
A systematic review and meta-analysis of the effects of antipsychotic medications on regional cerebral blood flow (rCBF) in schizophrenia: association with response to treatmentRhianna Goozée, Rowena Handley, Matthew J Kempton, et al.
International Clinical Psychopharmacology|November 21, 2012
Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trialsPaolo Fusar-Poli, Matthew J Kempton, Robert A Rosenheck
Journal of Psychopharmacology (Oxford, England)|December 11, 2014
Facial affect processing deficits in schizophrenia: a meta-analysis of antipsychotic treatment effectsAnthony S Gabay, Matthew J Kempton, Mitul A Mehta
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Journal of Medical Virology|April 1, 2020
Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysisMatthew J Kempton
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 9, 2021
Linking Brain Age to Psychopathology in AdolescenceMatthew J Kempton
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 6, 2014
How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?Matthew J Kempton, Philip McGuire
Biological Psychiatry|March 31, 2019
Reply to: Odds and Risk Ratios: When They Are Similar and When They Are NotAlexis E Cullen, Matthew J Kempton
JAMA Psychiatry|November 15, 2023
Concerns Regarding Strength of Conclusions in Systematic Review and Meta-Analysis of Neuroradiological Abnormalities in First-Episode Psychosis-ReplyGraham Blackman, Matthew J Kempton, Philip McGuire
Schizophrenia Research|March 19, 2025
A systematic review and meta-analysis of employer discrimination towards people living with psychosisNinon Crestois, Matthew J Kempton, Ricardo Twumasi
The Lancet. Psychiatry|August 30, 2016
Using machine learning to predict outcomes in psychosisJonathan Young, Matthew J Kempton, Philip McGuire
Neuroscience and Biobehavioral Reviews|April 3, 2014
A systematic review and meta-analysis of the effects of antipsychotic medications on regional cerebral blood flow (rCBF) in schizophrenia: association with response to treatmentRhianna Goozée, Rowena Handley, Matthew J Kempton, et al.
International Clinical Psychopharmacology|November 21, 2012
Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trialsPaolo Fusar-Poli, Matthew J Kempton, Robert A Rosenheck
Journal of Psychopharmacology (Oxford, England)|December 11, 2014
Facial affect processing deficits in schizophrenia: a meta-analysis of antipsychotic treatment effectsAnthony S Gabay, Matthew J Kempton, Mitul A Mehta
Pageof 14